EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62020TA0637
Case T-637/20: Judgment of the General Court of 6 October 2021 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VOLITE) (EU trade mark — Invalidity proceedings — EU word mark JUVÉDERM VOLITE — Late payment of the appeal fee — Inadmissibility of the appeal before the Board of Appeal — Article 101(4) of Regulation (EU) 2017/1001 — Article 106(1)(b) of Regulation 2017/1001 — Restitutio in integrum)
Case T-637/20: Judgment of the General Court of 6 October 2021 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VOLITE) (EU trade mark — Invalidity proceedings — EU word mark JUVÉDERM VOLITE — Late payment of the appeal fee — Inadmissibility of the appeal before the Board of Appeal — Article 101(4) of Regulation (EU) 2017/1001 — Article 106(1)(b) of Regulation 2017/1001 — Restitutio in integrum)
Case T-637/20: Judgment of the General Court of 6 October 2021 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VOLITE) (EU trade mark — Invalidity proceedings — EU word mark JUVÉDERM VOLITE — Late payment of the appeal fee — Inadmissibility of the appeal before the Board of Appeal — Article 101(4) of Regulation (EU) 2017/1001 — Article 106(1)(b) of Regulation 2017/1001 — Restitutio in integrum)
OJ C 481, 29.11.2021, p. 28–28
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
29.11.2021 |
EN |
Official Journal of the European Union |
C 481/28 |
Judgment of the General Court of 6 October 2021 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VOLITE)
(Case T-637/20) (1)
(EU trade mark - Invalidity proceedings - EU word mark JUVÉDERM VOLITE - Late payment of the appeal fee - Inadmissibility of the appeal before the Board of Appeal - Article 101(4) of Regulation (EU) 2017/1001 - Article 106(1)(b) of Regulation 2017/1001 - Restitutio in integrum)
(2021/C 481/40)
Language of the case: English
Parties
Applicant: Dermavita Company S.a.r.l. (Beirut, Lebanon) (represented by: D. Todorov, lawyer)
Defendant: European Union Intellectual Property Office (represented by: E. Markakis and V. Ruzek, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO: Allergan Holdings France SAS (Courbevoie, France)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 21 August 2020 (Case R 1015/2020-4), relating to invalidity proceedings between Dermavita Company and Allergan Holdings France.
Operative part of the judgment
The Court:
|
1. |
Dismisses the action; |
|
2. |
Orders Dermavita Company S.a.r.l. to pay the costs. |